How much profit has Inventiva made this year?
Inventiva has made -120.47 M EUR this year.
Inventiva Net Income 2024
Inventiva Net Income
-120.47 M EUR
Inventiva Dividend yield
Ticker
IVA.PA
ISIN
FR0013233012
WKN
A2DLV9
In 2024, Inventiva's profit amounted to -120.47 M EUR, a 9.09% increase from the -110.43 M EUR profit recorded in the previous year.
The Inventiva Net Income history
| YEAR | NET INCOME (undefined EUR) |
|---|---|
| 2029e | 6.91 |
| 2028e | -11.16 |
| 2027e | -49.4 |
| 2026e | -84.16 |
| 2025e | -100.62 |
| 2024e | -120.47 |
| 2023 | -110.43 |
| 2022 | -54.27 |
| 2021 | -49.64 |
| 2020 | -33.62 |
| 2019 | -30.22 |
| 2018 | -33.62 |
| 2017 | -19.08 |
| 2016 | -7.05 |
| 2015 | -8.82 |
| 2014 | -7.49 |
| 2013 | -7.14 |
Inventiva Aktienanalyse
What does Inventiva do?
Inventiva SA is a biopharmaceutical company based in France that specializes in the development of novel therapies for various diseases. The company was founded in 2002 by Pierre Broqua and Frédéric Cren to develop innovative drugs based on research on the human genome. Inventiva's business model is to develop a pipeline of drug candidates and either sell them or bring them into partnerships with other companies. The company has built a broad portfolio of patents and license agreements that allow it to develop a variety of products. Inventiva's research and development focuses on three key areas: fibrosis, oncology, and autoimmune diseases. In these areas, the company has several product candidates in various stages of clinical development. Inventiva's products include Lanifibranor, a drug for the treatment of fatty liver disease, which is currently in Phase III trials. Additionally, the company has several compounds in its oncology pipeline, including IVA337, IVA336, and IVA339, all of which have shown promising results in preclinical studies. In the field of autoimmune diseases, Inventiva is working on a compound called ABBV-157, which is being developed in collaboration with Abbvie. This compound is intended to help reduce inflammation in patients with rheumatoid arthritis and psoriasis. Overall, Inventiva has made significant progress in recent years and has achieved important milestones in the development of its products. The company has also entered into several partnerships with major pharmaceutical and biotech companies to bring its products to market. In 2020, Inventiva took the next important step in its growth strategy by announcing a merger with American company AbbVie. The acquisition is expected to accelerate the development and commercialization of Inventiva's products and provide the company with a strong partner in the international market. However, Inventiva has not limited itself to drug development. The company has also developed a range of services to support other companies in the development of new drugs. These include laboratory services, protein purification and analysis, cell culture, and more, offered through their own contract research organization (CRO) unit. In summary, Inventiva is an emerging company with a strong portfolio of products and services. The company has done excellent work in developing new medical technologies in recent years and is likely to have even more success in the future with the acquisition by AbbVie. Inventiva ist eines der beliebtesten Unternehmen auf Eulerpool.com.Net Income Details
Understanding Inventiva's Profit Margins
The profit margins of Inventiva represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Inventiva's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.
Year-to-Year Comparison
Evaluating Inventiva's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.
Impact on Investments
Inventiva's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.
Interpreting Profit Fluctuations
When Inventiva’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.
Frequently Asked Questions about Inventiva Stock
How has the profit developed compared to last year?
The profit has increased by 9.09% compared to last year increased
What impact do the earnings have on the shareholders?
An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.
How does Inventiva publish its earnings?
Inventiva publishes its earnings in the form of quarterly or annual reports.
Which financial indicators are included in the quarterly or annual reports?
The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.
Why is it important for investors to know the earnings of Inventiva?
The profits of Inventiva are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.
How can one learn more about the earnings of Inventiva?
You can learn more about the earnings of Inventiva by reviewing the quarterly or annual reports or following the company presentations.
How much dividend does Inventiva pay?
Over the past 12 months, Inventiva paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Inventiva is expected to pay a dividend of 0 EUR.
What is the dividend yield of Inventiva?
The current dividend yield of Inventiva is .
When does Inventiva pay dividends?
Inventiva pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Inventiva?
Inventiva paid dividends every year for the past 0 years.
What is the dividend of Inventiva?
For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.
In which sector is Inventiva located?
Inventiva is assigned to the 'Health' sector.
Wann musste ich die Aktien von Inventiva kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Inventiva from 5/27/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 5/27/2024.
When did Inventiva pay the last dividend?
The last dividend was paid out on 5/27/2024.
What was the dividend of Inventiva in the year 2023?
In the year 2023, Inventiva distributed 0 EUR as dividends.
In which currency does Inventiva pay out the dividend?
The dividends of Inventiva are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Inventiva
Our stock analysis for Inventiva Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Inventiva Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
